We are a rapidly growing life science technology company dedicated to pushing the boundaries of single-cell and spatial technologies. Our mission is to empower our customers by overcoming technological barriers in cutting-edge single-cell and spatial technologies, unraveling mysteries in life science, and driving advancements in disease diagnosis and treatment. With "M20 Seq" technology, we have pioneered the world's first high-throughput full-length single-cell technology sequencing using random primers, along with our VITA product line for single-cell transcriptome sequencing. In addition, our "M20 Spatial" technology, utilizing random primers and paired with our NATA spatial transcriptome product line, provides the first spatial full-transcriptome solution across various sample types.
| Website | https://www.m20genomics.com/ |
| Employees | 11 (9 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Spatial Technology, Life Science Technology, Genomics, Single Cell Analysis, Spatial Analysis, Biotechnology, Omics, Molecular Biology, Cell Biology, Transcriptomics, Proteomics, Next Generation Sequencing, Ngs, High Throughput Screening, Drug Discovery, Biomarker Discovery, Gene Expression, Cancer Research, Immunology |
Looking for a particular M20 Genomics employee's phone or email?
Ghee Lai is the Chief Strategy Officer and Head of Corporate Development of M20 Genomics.
9 people are employed at M20 Genomics.